Zarif met with Dr. Vicente Vérez Bencomo, director-general of the Finlay Institute of Vaccines (IFV) which is a Cuban epidemiological research institute, in Tehran on Monday, Press TV wrote.
The Cuban scientist provided explanations about the cooperation between the vaccine institutes of the two countries on the production of a COVID-19 vaccine and its unique features.
He thanked Zarif and the Iranian Foreign Ministry for working to advance bilateral cooperation swiftly towards developing the joint vaccine.
During the meeting, the Cuban ambassador to Tehran described as very important Zarif's last year visit to Havana at the start of cooperation between the Pasteur Institute of Iran (IPI) and the IFV for the joint production of the COVID-19 vaccine.
On Sunday, Vérez Bencomo held talks with Iran’s Health Minister Saeed Namaki and his deputies.
Speaking on the sidelines of the meeting, IPI head Alireza Biglari said that the third phase in the human trial of the joint vaccine is coming to an end in both Iran and Cuba, and that it has proved to be highly effective against variants of the coronavirus.
“The results of the clinical trial of the Soberana vaccine in Cuba demonstrate a 91.2-percent effectiveness against the strains in Cuba, South Africa and California, which are among the worst strains of the coronavirus,” he added.